An optimized in vitro assay for screening compounds that stimulate liver cell glucose utilization with low cytotoxicity

Journal of Pharmacological and Toxicological Methods

Volumn 56, Issue 1, 2007, Pages 58-62

  Zou, Chenhui ^a   Shen, Zhufang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cytotoxicity; Diabetes mellitus; Glucose utilization; HepG2; Method

Indexed keywords

CHIGLITAZAR; GLIBENCLAMIDE; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL SUSPENSION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DENSITY; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INOCULATION; LIVER CELL; REPRODUCIBILITY; SCREENING TEST;

CARBAZOLES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; GLUCOSE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; METFORMIN; PROPIONIC ACIDS; THIAZOLIDINEDIONES;

EID: 34249724970     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2006.12.005     Document Type: Article

References (12)

1. Bailey C.J., and Turner R.C. Metformin. New England Journal of Medicine 334 (1996) 574-579
2. Basu A., Basu R., Shah P., Vella A., Johnson C.M., Jensen M., et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: Additional evidence for a defect in hepatic glucokinase activity. Diabetes 50 (2001) 1351-1362
3. Basu A., Basu R., Shah P., Vella A., Johnson C.M., Nair K.S., et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: Evidence for a defect in hepatic glucokinase activity. Diabetes 49 (2000) 272-283
4. Cardin S., Emshwiller M., Jackson P.A., Snead W.L., Hastings J., Edgerton D.S., et al. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats. Journal of Applied Physiology 87 (1999) 1470-1475
5. Friedman J. Fat in all the wrong places. Nature 415 (2002) 268-269
6. Kadish A.H., Litle R.L., and Sternberg J.C. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clinical Chemistry 14 (1968) 116-131
7. Löhrke B., Shahi S.K., Krüger B., Schmidt P., Renne U., and Dietl G. Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor ? in cells adjacent to the murine skeletal muscle: Implications for fibroblast functions. European Journal of Physiology 439 (2000) 288-296
8. Oakes N.D., Thalen P., Hultstrand T., Jacinto S., Camejo G., Wallin B., et al. Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 289 (2005) R938-R946
9. Proks P., Reimann F., Green N., Gribble F., and Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes 51 (2002) S368-S376
10. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
11. Semple R.K., Chatterjee V.K.K., and O'Rahilly S. PPAR{gamma} and human metabolic disease. Journal of Clinical Investigation 116 (2006) 581-589
12. Yin J., Hu R., Chen M., Tang J., Li F., Yang Y., et al. Effects of berberine on glucose metabolism in vitro. Metabolism 51 (2002) 1439-1443